Journal of Nutrition EB Program 2010 Early Registration

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, B.
Right arrow Articles by Moon, S.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, B.
Right arrow Articles by Moon, S.-K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
© 2005 American Society for Nutrition J. Nutr. 135:2767-2773, December 2005


Biochemical and Molecular Actions of Nutrients

Resveratrol Inhibits TNF-{alpha}–Induced Proliferation and Matrix Metalloproteinase Expression in Human Vascular Smooth Muscle Cells

Beobyi Lee and Sung-Kwon Moon*,1

Department of Anatomy, College of Medicine, Konkuk University, Chungju City, Chungbuk 380–701, South Korea and * Department of Food and Biotechnology, Chungju National University, Chungju, Chungbuk 380–702, South Korea

1To whom correspondence should be addressed. E-mail: sumoon66{at}dreamwiz.com.

ABSTRACT

Resveratrol (RV), a polyphenolic substance found in grape skin, was suggested to play a role in preventing the development of atherosclerotic disease. Although RV has antiatherogenic effects on vascular smooth muscle cells (VSMC), the molecular mechanisms associated with tumor necrosis factor (TNF)-{alpha}–induced VSMC are unclear. The goal of this study was to determine the effect of RV on the modulation of cell proliferation, cell-cycle regulation, and matrix metalloproteinase (MMP)-9 expression in TNF-{alpha}–induced human VSMC. RV treatment inhibited DNA synthesis in cultured VSMC in the presence of TNF-{alpha}. These inhibitory effects were associated with reduced levels of extracellular signal-regulated kinase (ERK) 1/2 activity and G1 cell-cycle arrest. Treatment with RV, which blocks the cell cycle in the G1 phase, downregulated the expression of cyclins and cyclin-dependent kinases (CDKs) and upregulated the expression of p21/WAF1, a CDK inhibitor. RV did not upregulate p27. Moreover, RV increased the promoter activity of the p21/WAF1 gene. Immunoblot and deletion analysis of the p21/WAF1 promoter showed that RV induced the expression of p21/WAF1 and that this expression was independent of the p53 pathway. Furthermore, zymographic and immunoblot analyses showed that RV dose dependently suppressed the TNF-{alpha}–induced expression of MMP-9. This inhibition was characterized by the downregulation of MMP-9, which was transcriptionally regulated at the activator protein-1 (AP-1) and nuclear factor-{kappa}B (NF-{kappa}B) sites in the MMP-9 promoter. Collectively, these results suggest that RV inhibits cell proliferation, G1 to S phase cell-cycle progress, and MMP-9 expression through the transcription factors NF-{kappa}B and AP-1 in TNF-{alpha}–induced VSMC.


KEY WORDS: • resveratrol • vascular smooth muscle cell • matrix metalloproteinase-9 • G1 cell-cycle arrest







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by American Society for Nutrition